Flunarizine's Effect on Red Blood Cell Viscosity in Tumors
Author Information
Author(s): B.D. Kavanagh, B.E. Coffey, D. Needham, R.M. Hochmuth, M.W. Dewhirst
Primary Institution: Duke University Medical Center
Hypothesis
Metabolic conditions in solid tumors reduce red blood cell deformability, and flunarizine prevents this loss.
Conclusion
Flunarizine improves blood flow and oxygenation in tumors by enhancing the flow properties of red blood cells.
Supporting Evidence
- Flunarizine at concentrations of 5 and 10 mg/l prevented increases in viscosity.
- Hypoxia increased viscosity by an average of 23%, which was statistically significant.
- Flunarizine caused a dose-dependent shift toward lower cell density.
- Stomatocytes were significantly increased in both rat and human cells after flunarizine treatment.
Takeaway
Flunarizine helps red blood cells move better in tumors, making it easier for them to deliver oxygen.
Methodology
A microrheometer was used to measure the viscosity of rat and human red blood cell suspensions under hypoxic, acidic, and lactate conditions, with and without flunarizine.
Limitations
The study primarily involved animal models and may not fully translate to human conditions.
Participant Demographics
Five healthy human volunteers and three healthy rats were used in the study.
Statistical Information
P-Value
0.03
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website